HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of carbon-11-labeled tariquidar derivatives as new PET agents for imaging of breast cancer resistance protein (ABCG2).

Abstract
Carbon-11-labeled tariquidar derivatives were first designed and synthesized as new PET agents for imaging of breast cancer resistance protein. The target tracers were prepared by O-[(11)C]methylation of their corresponding acid precursors using [(11)C]CH3OTf under basic conditions and isolated by a simplified solid-phase extraction (SPE) method in 50-60% radiochemical yields based on [(11)C]CO(2) and decay corrected to end of bombardment (EOB). The overall synthesis time from EOB was 15-20 min, the radiochemical purity was >99%, and the specific activity at end of synthesis (EOS) was 111-185 GBq/micromol.
AuthorsMin Wang, David X Zheng, Michael B Luo, Mingzhang Gao, Kathy D Miller, Gary D Hutchins, Qi-Huang Zheng
JournalApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine (Appl Radiat Isot) Vol. 68 Issue 6 Pg. 1098-103 (Jun 2010) ISSN: 1872-9800 [Electronic] England
PMID20181488 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Carbon Radioisotopes
  • Neoplasm Proteins
  • Quinolines
  • tariquidar
Topics
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters (analysis)
  • Breast Neoplasms (diagnostic imaging)
  • Carbon Radioisotopes
  • Female
  • Humans
  • Isotope Labeling (methods)
  • Neoplasm Proteins (analysis)
  • Positron-Emission Tomography (methods)
  • Quinolines (chemical synthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: